 |
 |
 |
 |
| |
Research News | Drug News | Conference News
News Brief: ALS Drug Olesoxime Fails in Phase 3 Trial
December 16, 2011
The ALS drug olesoxime failed to achieve the desired survival effect in a Phase 3 clinical trial...
Did MicroRNAs Orchestrate the Human Brain Boom?
December 16, 2011
Humankind may owe its outsized intelligence to our microRNAs...
ALS Muscle Matters: Biopsy and Frog Egg Models Probe Pathology
December 12, 2011
Scientists are now starting to focus more on muscle pathology in ALS...
TDP-43 Hangs Out With NF-κB, Puts Innate Immunity Into Hyperdrive
December 2, 2011
TAR DNA binding protein 43, is in the middle of an abnormal innate immune response that compromises the spinal cord of people with the disease...
DC: Targeting Toxic Extrasynaptic Signaling in HD and AD
December 2, 2011
In neuronal transmission, as in real estate, location is everything. When N-methyl D-aspartate (NMDA) glutamate receptors sit in the synapse, they behave ...
Research News has been provided in partnership with alzforum.org |
|
|
 |
|
 |
|
|
|
|
